Jerry T Wu
Overview
Explore the profile of Jerry T Wu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
48
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tian M, Wei J, Cheuk A, Milewski D, Zhang Z, Kim Y, et al.
Nat Commun
. 2024 Jul;
15(1):6222.
PMID: 39043633
Chimeric antigen receptor (CAR) T-cells targeting Fibroblast Growth Factor Receptor 4 (FGFR4), a highly expressed surface tyrosine receptor in rhabdomyosarcoma (RMS), are already in the clinical phase of development, but...
2.
Tian M, Wei J, Shivaprasad N, Highfill S, Gryder B, Milewski D, et al.
Cell Rep Med
. 2024 May;
5(5):101586.
PMID: 38723625
No abstract available.
3.
Tian M, Wei J, Shivaprasad N, Highfill S, Gryder B, Milewski D, et al.
Cell Rep Med
. 2023 Sep;
4(10):101212.
PMID: 37774704
Pediatric patients with relapsed or refractory rhabdomyosarcoma (RMS) have dismal cure rates, and effective therapy is urgently needed. The oncogenic receptor tyrosine kinase fibroblast growth factor receptor 4 (FGFR4) is...
4.
Wu J, Cheuk A, Isanogle K, Robinson C, Zhang X, Ceribelli M, et al.
Cancers (Basel)
. 2023 Aug;
15(16).
PMID: 37627061
Rhabdomyosarcoma (RMS) is the most common pediatric soft tissue sarcoma. Despite decades of clinical trials, the overall survival rate for patients with relapsed and metastatic disease remains below 30%, underscoring...
5.
Bahramian E, Furr M, Wu J, Ceballos R
Front Immunol
. 2022 Aug;
13:847106.
PMID: 35911725
Within the family , sub-family , and genus , there are only three human herpesviruses that have been described: HHV-6A, HHV-6B, and HHV-7. Initially, HHV-6A and HHV-6B were considered as...
6.
Tian M, Cheuk A, Wei J, Abdelmaksoud A, Chou H, Milewski D, et al.
J Clin Invest
. 2022 Jul;
132(16).
PMID: 35852863
Chimeric antigen receptor (CAR) T cell therapies targeting single antigens have performed poorly in clinical trials for solid tumors due to heterogenous expression of tumor-associated antigens (TAAs), limited T cell...